<DOC>
	<DOCNO>NCT01332981</DOCNO>
	<brief_summary>This observational follow-up study efficacy 1st-line treatment Herceptin ( trastuzumab ) patient metastatic breast cancer 7 year initiation treatment .</brief_summary>
	<brief_title>An Observational Follow-up Study 1st-Line Treatment With Herceptin ( Trastuzumab ) Patients With Metastatic Breast Cancer ( Post-HERMINE )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>Female patient , &gt; /= 18 year age Metastatic breast cancer 1stline treatment Herceptin initiated 2002 Included pharmacoepidemiologic HERMINE study Patient die schedule followup visit ( March 2005 )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>